Holen Sie sich die Stockscreener-App
52.53
0.83%
0.43
Handel nachbörslich:
52.53
Livanova Plc Aktie (LIVN) Neueste Nachrichten
LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint - Yahoo Finance
Cornercap Investment Counsel Inc. Sells 10,684 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Position Boosted by Victory Capital Management Inc. - MarketBeat
Entropy Technologies LP Buys Shares of 10,067 LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova (NASDAQ:LIVN) Cut to "Buy" at StockNews.com - MarketBeat
State of New Jersey Common Pension Fund D Raises Stock Holdings in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences - Business Wire
Medical Implants Market Is Booming Worldwide 2024-2031 | Biotronik, Inc., Livanova Plc, NuVasive - openPR
LivaNova (NASDAQ:LIVN) Given Buy Rating at Needham & Company LLC - MarketBeat
LivaNova PLC (LIVN) SEC Filing Summary - Quartzy
Shareholders Will Be Pleased With The Quality of LivaNova's (NASDAQ:LIVN) Earnings - Yahoo Finance UK
We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve - Simply Wall St
Vagus Nerve Stimulation (VNS) Market Market Size, Trends, - openPR
LivaNova announces OSPREY clinical study meets safety/efficacy endpoints - TipRanks
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints - sharewise
LivaNova reports positive results in sleep apnea trial By Investing.com - Investing.com South Africa
LivaNova reports positive results in sleep apnea trial - Investing.com India
LivaNova plc (LIVN) Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints - StreetInsider.com
Blood Recovery Machine Market is expected to reach revenue of USD 4,277.4 Mn by 2033, at 5.9% CAGR: Dimension Market Research. - GlobeNewswire Inc.
LivaNova (NASDAQ:LIVN) Upgraded by StockNews.com to Strong-Buy Rating - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
LivaNova (LIVN) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
How Much Upside is Left in LivaNova (LIVN)? Wall Street Analysts Think 38.2% - Yahoo Finance
Chest Drainage Catheters Market Driven by Advancements in Medical Devices | LivaNova PLC, Mediplus, - EIN News
Oversold Conditions For LivaNova (LIVN) - Nasdaq
LivaNova (NASDAQ:LIVN) Trading Down 3.9%Should You Sell? - MarketBeat
LivaNova Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Nisa Investment Advisors LLC Lowers Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Is a LivaNova PLC (LIVN) Promising Medical Stock with Growth Potential? - Insider Monkey
Emerald Advisers LLC Purchases 14,302 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year - Simply Wall St
Earnings Beat: LivaNova PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Where are the Opportunities in (LIVN) - Stock Traders Daily
abrdn plc Purchases 70,618 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova maintains VNS Therapy classification By Investing.com - Investing.com Australia
LivaNova maintains VNS Therapy classification - Investing.com India
LivaNova price target raised to $72 from $66 at Baird - TipRanks
Mizuho Cuts LivaNova (NASDAQ:LIVN) Price Target to $70.00 - MarketBeat
LivaNova price target lowered to $70 from $80 at Mizuho - TipRanks
LivaNova (NASDAQ:LIVN) Earns "Buy" Rating from Needham & Company LLC - MarketBeat
Robert W. Baird Forecasts Strong Price Appreciation for LivaNova (NASDAQ:LIVN) Stock - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: LivaNova reports robust Q3 growth, raises 2024 outlook By Investing.com - Investing.com South Africa
Is Now An Opportune Moment To Examine LivaNova PLC (NASDAQ:LIVN)? - Yahoo Finance
Earnings call: LivaNova reports robust Q3 growth, raises 2024 outlook - Investing.com India
LivaNova PLC (LIVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Yahoo Finance
LivaNova PLC (LIVN) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
LivaNova PLC Reports Strong Q3 2024 Results - TipRanks
LivaNova: Q3 Earnings Snapshot - Houston Chronicle
LivaNova PLC Q3 2024 Earnings: EPS of $0.60 Beats Estimates, Rev - GuruFocus.com
LivaNova beats Q3 expectations, raises 2024 guidance By Investing.com - Investing.com Nigeria
LivaNova (NASDAQ:LIVN) Shares Gap UpShould You Buy? - MarketBeat
LivaNova PLC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
LivaNova (NASDAQ:LIVN) Releases FY 2024 Earnings Guidance - MarketBeat
LivaNova PLC earnings beat by $0.18, revenue topped estimates - Investing.com Australia
Q3 2024 LivaNova PLC Earnings Call Transcript - GuruFocus.com
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):